• Novum IQ Infusion Platform now offers large volume and syringe infusion smart pumps on an integrated system with shared innovative digital health solutions to help enhance patient safety and efficiency for clinicians
• Common user interface and connectivity across both pump modalities are designed to help reduce workflow burden and allow more time focused on patient care
Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite – enables clinicians to utilize a single, integrated system across a variety of patient care settings. Offering the Novum IQ LVP in the U.S. demonstrates Baxter’s commitment to continued innovation in advancing infusion therapy. Read more >
Our 90-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.
This post is related to:
Contamination Control: Cleanroom Supplies, Disposables Compounding: Closed System Drug-Transfer Devices (CSTDs) Practice Setting: Health System Pharmacy Resources Practice Setting: Infusion Pharmacy Resources Manufacturing: Injectables Compounding: IV/Infusion Resources/USP <797> Resources Automation: Pharmacy Fulfillment Robots Compounding: USP <800> Compliance
